Edwina H Yeung1, Pauline Mendola2, Rajeshwari Sundaram3, Tzu-Chun Lin4, Miranda M Broadney5, Diane L Putnick5, Sonia L Robinson5, Kristen J Polinski5, Jean Wactawski-Wende2, Akhgar Ghassabian6, Thomas G O'Connor7, Robert E Gore-Langton8, Judy E Stern9, Erin Bell10. 1. Epidemiology Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland. Electronic address: yeungedw@mail.nih.gov. 2. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York. 3. Biostatistics & Bioinformatics Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland. 4. Glotech, Inc., Rockville, Maryland. 5. Epidemiology Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland. 6. Departments of Pediatrics, Population Health, and Environmental Medicine, New York University School of Medicine, New York, New York. 7. Departments of Psychiatry, Psychology, Neuroscience, Obstetrics and Gynecology, University of Rochester, Rochester, New York. 8. Emmes, Rockville, Maryland. 9. Department of Obstetrics and Gynecology, Dartmouth-Hitchcock and Dartmouth Geisel Medical School, Lebanon, New Hampshire. 10. Department Epidemiology and Biostatistics, University at Albany School of Public Health, Albany, New York.
Abstract
OBJECTIVE: To evaluate whether children conceived using assisted reproductive technology (ART) or ovulation induction (OI) have greater cardiometabolic risk than children conceived without treatment. DESIGN: Clinical assessments in 2018-2019 in the Upstate KIDS cohort. SETTING: Clinical sites in New York. PATIENT(S): Three hundred thirty-three singletons and 226 twins from 448 families. INTERVENTION(S): Mothers reported their use of fertility treatment and its specific type at baseline and approximately 4 months after delivery. High validity of the self-reported use of ART was previously confirmed. The children were followed up from infancy through 8-10 years of age. A subgroup was invited to participate in clinic visits. MAIN OUTCOME MEASURE(S): The measurements of blood pressure (BP), arterial stiffness using pulse wave velocity, anthropometric measures, and body fat using bioelectrical impedance analysis were performed (n = 559). The levels of plasma lipids, C-reactive protein, and hemoglobin A1c were measured using blood samples obtained from 263 children. RESULT(S): The average age of the children was 9.4 years at the time of the clinic visits Approximately 39% were conceived using fertility treatment (18% using ART and 21% using OI). Singletons conceived using fertility treatment (any type or using ART or OI specifically) did not statistically differ in systolic or diastolic BP, heart rate, or pulse wave velocity. Singletons conceived using OI were smaller than singletons conceived without treatment, but the average body mass index of the latter was higher (z-score: 0.41 [SD, 1.24]) than the national norms. Twins conceived using either treatment had lower BP than twins conceived without treatment. However, twins conceived using OI had significantly higher arterial stiffness (0.59; 95% CI, 0.03-1.15 m/s), which was attenuated after accounting for maternal BP (0.29; 95% CI, -0.03 to 0.46 m/s). Twins did not significantly differ in size or fat measures across the groups. The mode of conception was not associated with the levels of lipids, C-reactive protein, or glycosylated hemoglobin. CONCLUSION(S): Clinical measures at the age of 9 years did not indicate greater cardiometabolic risk in children conceived using ART or OI compared with that in children conceived without treatment. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov #NCT03106493. Published by Elsevier Inc.
OBJECTIVE: To evaluate whether children conceived using assisted reproductive technology (ART) or ovulation induction (OI) have greater cardiometabolic risk than children conceived without treatment. DESIGN: Clinical assessments in 2018-2019 in the Upstate KIDS cohort. SETTING: Clinical sites in New York. PATIENT(S): Three hundred thirty-three singletons and 226 twins from 448 families. INTERVENTION(S): Mothers reported their use of fertility treatment and its specific type at baseline and approximately 4 months after delivery. High validity of the self-reported use of ART was previously confirmed. The children were followed up from infancy through 8-10 years of age. A subgroup was invited to participate in clinic visits. MAIN OUTCOME MEASURE(S): The measurements of blood pressure (BP), arterial stiffness using pulse wave velocity, anthropometric measures, and body fat using bioelectrical impedance analysis were performed (n = 559). The levels of plasma lipids, C-reactive protein, and hemoglobin A1c were measured using blood samples obtained from 263 children. RESULT(S): The average age of the children was 9.4 years at the time of the clinic visits Approximately 39% were conceived using fertility treatment (18% using ART and 21% using OI). Singletons conceived using fertility treatment (any type or using ART or OI specifically) did not statistically differ in systolic or diastolic BP, heart rate, or pulse wave velocity. Singletons conceived using OI were smaller than singletons conceived without treatment, but the average body mass index of the latter was higher (z-score: 0.41 [SD, 1.24]) than the national norms. Twins conceived using either treatment had lower BP than twins conceived without treatment. However, twins conceived using OI had significantly higher arterial stiffness (0.59; 95% CI, 0.03-1.15 m/s), which was attenuated after accounting for maternal BP (0.29; 95% CI, -0.03 to 0.46 m/s). Twins did not significantly differ in size or fat measures across the groups. The mode of conception was not associated with the levels of lipids, C-reactive protein, or glycosylated hemoglobin. CONCLUSION(S): Clinical measures at the age of 9 years did not indicate greater cardiometabolic risk in children conceived using ART or OI compared with that in children conceived without treatment. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov #NCT03106493. Published by Elsevier Inc.
Authors: T G Papaioannou; A D Protogerou; E G Nasothimiou; D Tzamouranis; N Skliros; A Achimastos; D Papadogiannis; C I Stefanadis Journal: J Hum Hypertens Date: 2011-08-11 Impact factor: 3.012
Authors: Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais Journal: Eur Heart J Date: 2018-09-01 Impact factor: 29.983
Authors: Jane Halliday; Sharon Lewis; Joanne Kennedy; David P Burgner; Markus Juonala; Karin Hammarberg; David J Amor; Lex W Doyle; Richard Saffery; Sarath Ranganathan; Liam Welsh; Michael Cheung; John McBain; Stephen J C Hearps; Robert McLachlan Journal: Fertil Steril Date: 2019-04-16 Impact factor: 7.329
Authors: Bastiaan T Heijmans; Elmar W Tobi; Aryeh D Stein; Hein Putter; Gerard J Blauw; Ezra S Susser; P Eline Slagboom; L H Lumey Journal: Proc Natl Acad Sci U S A Date: 2008-10-27 Impact factor: 11.205
Authors: S Mintjens; M D Menting; R J B J Gemke; M N M van Poppel; M van Wely; A J Bensdorp; R I Tjon Kon Fat; B W J Mol; R C Painter; C van de Beek; T J Roseboom Journal: Eur J Obstet Gynecol Reprod Biol Date: 2019-09-26 Impact factor: 2.435
Authors: Edwina H Yeung; Pauline Mendola; Rajeshwari Sundaram; Xuehuo Zeng; Weihua Guan; Michael Y Tsai; Sonia L Robinson; Judy E Stern; Akhgar Ghassabian; David Lawrence; Thomas G O'Connor; James Segars; Robert E Gore-Langton; Erin M Bell Journal: Fertil Steril Date: 2021-04-03 Impact factor: 7.490
Authors: F Belva; M Bonduelle; S Provyn; R C Painter; H Tournaye; M Roelants; J De Schepper Journal: Int J Endocrinol Date: 2018-05-03 Impact factor: 3.257